News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|December 22, 2022

Stages and Progression of T1D

Author(s)Tina Q Tan, MD, FAAP, FIDSA, FPIDS, Kimberly Simmons, MD

Kimberly Simmons, MD, reviews stages 1, 2, and 3 of pediatric T1D progression.

Episodes in this series

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 2 Stages and Progression of T1D

EP. 2 Stages and Progression of T1D

EP. 3 Importance of Screening for T1D

EP. 3 Importance of Screening for T1D

EP. 4 Lifestyle Management in T1D

EP. 4 Lifestyle Management in T1D

EP. 5 Approaching T1D Screening Retesting

EP. 5 Approaching T1D Screening Retesting

EP. 6 Emerging Treatments in T1D

EP. 6 Emerging Treatments in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care | Image Credit: © H_Ko - stock.adobe.com.

Redefining type 1 diabetes: Early identification, staging, and clinical implications for pediatric care

ByHerb Bravo, MD,Dan Feiten, MD,Andrew Cagle, MD

November 20th 2025

Artificial sweeteners show mixed effects on diabetes management | Image Credit: © Proxima Studio - stock.adobe.com.

Artificial sweeteners show mixed effects on diabetes management

ByMorgan Ebert, Managing Editor

November 2nd 2025

Novel therapies for type 1 diabetes | Image Credit: © martenaba - stock.adobe.com.

Novel therapies for type 1 diabetes

ByMichelle Nieland, PharmD ,Carlton Lee, PharmD, MPH, FASHP, FPPAG, BCPPS

November 1st 2025

FDA accepts Afrezza sBLA for pediatric diabetes | Image credit: Contemporary Pediatrics

FDA accepts Afrezza sBLA for pediatric diabetes

ByMorgan Ebert, Managing Editor,Joshua Fitch, Senior Editor

October 13th 2025

What to expect from the 2025 AAP National Conference & Exhibition | Image Credit: © KOTO - stock.adobe.com.

What to expect from the 2025 American Academy of Pediatrics National Conference & Exhibition

ByJoshua Fitch, Senior Editor

September 23rd 2025

Latest CME

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

ACIP votes to update hepatitis B vaccine recommendation for infants

New analysis highlights nirsevimab as most impactful RSV prevention strategy for infants

Repeal of nonmedical exemptions linked to rise in kindergarten vaccination rates

Christine Eng, MD, on addressing barriers to exome and genome sequencing in clinical practice

FDA expands indication for MED-EL cochlear implants to infants 7 months or older

© 2025 MJH Life Sciences^®

All rights reserved.